Patent · US Active

Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists

US9150550B2 · kind B2 · utility

2Cited by

0References

14Claims

0Family size

Assignee

CHEMOCENTRYX, INC. · US

Inventors

Manmohan Reddy Leleti · Sunnyvale, US
Yandong Li · San Jose, US
Venkat Reddy Mali · Cupertino, US
Jay P. Powers · Pacifica, US
Ju Yang · Palo Alto, US

Key dates

Filing date	Oct 17, 2013
Grant date	Oct 6, 2015
Priority date	—
Expiry date	Oct 17, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Benzimidazole, benzopyrazole and benzotriazole compounds are provided which bind to CCR(4) and are useful for the treatment of diseases such as allergic diseases, autoimmune diseases, graft rejection and cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.